Pesquisas alternativas:
cancer frequent » cancer frequency (Expandir a Pesquisa), causes frequent (Expandir a Pesquisa), center frequency (Expandir a Pesquisa)
frequent clinic » frequent clinical (Expandir a Pesquisa), frequency clinico (Expandir a Pesquisa), frequent clique (Expandir a Pesquisa)
clinic oncol » clinic one (Expandir a Pesquisa)
cancer real » cancer renal (Expandir a Pesquisa), cancer reveal (Expandir a Pesquisa), cancer rectal (Expandir a Pesquisa)
j cancer » j canter (Expandir a Pesquisa), 0 cancer (Expandir a Pesquisa), j cancel (Expandir a Pesquisa)
1 cancer » al cancer (Expandir a Pesquisa)
cancer frequent » cancer frequency (Expandir a Pesquisa), causes frequent (Expandir a Pesquisa), center frequency (Expandir a Pesquisa)
frequent clinic » frequent clinical (Expandir a Pesquisa), frequency clinico (Expandir a Pesquisa), frequent clique (Expandir a Pesquisa)
clinic oncol » clinic one (Expandir a Pesquisa)
cancer real » cancer renal (Expandir a Pesquisa), cancer reveal (Expandir a Pesquisa), cancer rectal (Expandir a Pesquisa)
j cancer » j canter (Expandir a Pesquisa), 0 cancer (Expandir a Pesquisa), j cancel (Expandir a Pesquisa)
1 cancer » al cancer (Expandir a Pesquisa)
1
“... registry (TR) staff, and hospital leadership. The group identified three key barriers to reporting: (1...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Benavides, M., Antón, A., Gallego, J., Gómez, M. A., Jiménez-Gordo, A., La Casta, A., Laquente, B., Macarulla, T., Rodríguez-Mowbray, J. R., Maurel, J.
Publicado no Clin Transl Oncol (2015)
Assuntos:
“...Clinical Guides in Oncology...”Publicado no Clin Transl Oncol (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
“... avoids frequent clinical visits as well as insertion of central venous catheters. The impact...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Novetsky, Akiva P., Zighelboim, Israel, Thompson, Dominic M., Powell, Matthew A., Mutch, David G., Goodfellow, Paul J.
Publicado em 2012
“... by The Cancer Genome Atlas(TCGA) as mutated in endometrioid endometrial cancer, and determine the relationship...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
“... is frequently dysregulated in cancer has uncovered an entirely new repertoire of molecular factors upstream...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Zhuge, Yan, Lagman, Jo Ann J., Ansenberger, Kristine, Mahon, Cassandra J., Daikoku, Takiko, Dey, Sudhansu K., Bahr, Janice M., Hales, Dale B.
Publicado em 2008
“... and initiate ovarian epithelial cancer. Our objectives were to evaluate CYP1B1 expression, distribution...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Mamtani, Anita, Gonzalez, Julie J., Neo, Dayna, Slanetz, Priscilla J., Houlihan, Mary Jane, Herold, Christina I., Recht, Abram, Hacker, Michele R., Sharma, Ranjna
Publicado no Ann Surg Oncol (2016)
“...-stage (stages 1 or 2) breast cancer but used less often for elderly women. METHODS: This retrospective...”Publicado no Ann Surg Oncol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Courneya, K.S., Booth, C.M., Gill, S., O’Brien, P., Vardy, J., Friedenreich, C.M., Au, H.J., Brundage, M.D., Tu, D., Dhillon, H., Meyer, R.M.
Publicado em 2008
Assuntos:
“...Cancer Rehabilitation and Survivorship...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Artigo
9
“... of Cancer Quality of Life Questionnaire (version 3.0) was used to assess the qol of npc survivors. Multiple...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
“... manifestations were compared between the groups. RESULTS: Early gastric cancer was more frequent (30.1% vs. 4...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Ong, Zhi Yi, Gibson, Rachel J, Bowen, Joanne M, Stringer, Andrea M, Darby, Jocelyn M, Logan, Richard M, Yeoh, Ann SJ, Keefe, Dorothy M
Publicado em 2010
“...BACKGROUND: Mucositis is a toxic side effect of anti-cancer treatments and is a major focus...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
“...The increasing proportion of human papilloma virus-related oropharynx cancers has led to improved...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
“...BACKGROUND: The management of small-cell lung cancer (sclc) with radiotherapy (rt) varies...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Zurita, A. J., George, D. J., Shore, N. D., Liu, G., Wilding, G., Hutson, T. E, Kozloff, M., Mathew, P., Harmon, C. S, Wang, S. L., Chen, I., Chow Maneval, E., Logothetis, C. J.
Publicado no Ann Oncol (2012)
“... was prostate-specific antigen (PSA) response rate. RESULTS: One phase 1 dose-limiting toxicity occurred (grade...”Publicado no Ann Oncol (2012)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Hirasawa, Akira, Makita, Kazuya, Akahane, Tomoko, Yokota, Megumi, Yamagami, Wataru, Banno, Kouji, Susumu, Nobuyuki, Aoki, Daisuke
Publicado em 2013
“...OBJECTIVE: Previous studies have reported an association between endometrial cancer and the risk...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Assuntos:
“...Clinical Investigations...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Phase I Clinical Trial of the CYP17 Inhibitor Abiraterone Acetate Demonstrating Clinical Activity...
Por Ryan, Charles J., Smith, Matthew R., Fong, Lawrence, Rosenberg, Jonathan E., Kantoff, Philip, Raynaud, Florence, Martins, Vanessa, Lee, Gloria, Kheoh, Thian, Kim, Jennifer, Molina, Arturo, Small, Eric J.
Publicado em 2010
“... cancers (CRPCs), extragonadal androgen sources may sustain tumor growth despite a castrate environment...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Zaal, Afra, Peyrot, Wouter J., Berns, P. M. J. J., van der Burg, Maria E. L., Veerbeek, Jan H. W., Trimbos, J. Baptist, Cadron, Isabelle, van Diest, Paul J., van Wieringen, Wessel N., Krijgsman, Oscar, Meijer, Gerrit A., Piek, Jurgen M. J., Timmers, Petra J., Vergote, Ignace, Verheijen, René H. M., Ylstra, Bauke, Zweemer, Ronald P.
Publicado em 2012
“... cancer equalled those in early stage, but were more frequent in advanced stage (p = 0.012). Unsupervised...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Kamal, Arif H., Swetz, Keith M., Carey, Elise C., Cheville, Andrea L., Liu, Heshan, Ruegg, Suzanne R., Moynihan, Timothy J., Sloan, Jeff A., Kaur, Judith S.
Publicado em 2011
“... and Cox survival models. RESULTS: Cancer was the most common primary diagnosis (47%) in the 1,794 patients...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Udager, A. M., Liu, T.-Y., Skala, S. L., Magers, M. J., McDaniel, A. S., Spratt, D. E., Feng, F. Y., Siddiqui, J., Cao, X., Fields, K. L., Morgan, T. M., Palapattu, G. S., Weizer, A. Z., Chinnaiyan, A. M., Alva, A., Montgomery, J. S., Tomlins, S. A., Jiang, H., Mehra, R.
Publicado no Ann Oncol (2016)
“... to assess the incidence and potential clinical significance of PD-L1 expression in penile SqCC. PATIENTS...”Publicado no Ann Oncol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo